Common Stock SEC Reporting - Current
Verified Company Profile 7/24/2017
Contact Info
  • 1111 Main Street
  • Suite 660
  • Vancouver, WA 98660

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report May 31, 2017 10-K
CIK 0001175680
Fiscal Year End 5/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2003
Employees 6 a/o Jul 24, 2017
Company Officers/Contacts
Nader Z, Pourhassan, Ph.D. CEO, President
Michael D. Mulholland CFO, Treasurer, Corporate Secretary
Denis R. Burger, Ph.D. Chief Scientific Officer
Tracie L. Melchior, CPA Director of Accounting
Company Directors
Anthony D. Caracciolo Executive Chairman
Gregory A Gould, CPA
Carl C. Dockery
Scott Kelly
A. Bruce Montgomery, M.D.
Jordan G. Naydenov
Denis R. Burger, Ph.D.
Nader Z, Pourhassan, Ph.D.
Service Providers
Accounting/Auditing Firm
Warren Averett, LLC
100 South Ashley Drive
Suite 1650
Tampa, FL, 33602
United States

Legal Counsel
Lowenstein Sandler PC
1251 Avenue of the Americas
New York, NY, 10021
United States

Investor Relations Firm
44 Montgomery Street
Suite 200
San Francisco, CA, 94104
United States

CYDY Security Details
Share Structure
Market Value1 $97,768,476 a/o Sep 22, 2017
Authorized Shares 200,000,000 a/o Sep 21, 2017
Outstanding Shares 156,099,574 a/o Sep 21, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC 85,627,455 a/o Sep 21, 2017
Float 84,065,617 a/o Nov 30, 2016
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
Shareholders of Record 540 a/o Jul 20, 2017
Short Selling Data
Short Interest 285,262 (-1.47%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security